IMVIQ
|
These results do not appear to be spectacular but my scientific knowledge is...
|
IMVIQ
|
Conclusion • Increases in both T and B cell immune infiltration in tumors...
|
T.IVN
|
Currently up .57 cents. If normal pattern persists,I expect we will close...
|
T.IVN
|
Surprised we are still going south. IVN tried to stabilize share price...
|
T.IVN
|
Hope you are right non c, but these past few days seem a bit unusual.We are...
|
IMVIQ
|
These results seem very good but don't appear to impress the market much....
|
IMVIQ
|
DECEMBER 02, 2021 7:05AM EST Translational data show that...
|
IMVIQ
|
Seems a bit to early for tax loss selling but maybe.My impression is that...
|
IMVIQ
|
We are scheduled to receive a couple of updates by end of the month.One for...
|
T.IVN
|
This chart shows copper price could dive 28% going into 2022 Frik Els...
|
IMVIQ
|
Press Releases ...
|
T.IVN
|
Backwardation in copper is hitting the copper stocks.Not so long ago,the...
|
T.ATE
|
Antibe Therapeutics Inc: Canaccord Genuity cuts to "hold" from...
|
IMVIQ
|
Alpha,I would also appreciate more details from the WF report.Not sure I...
|
T.ATE
|
As soon as I read the NR yesterday, I sold my ATE shares @$1.11. I'm too...
|
IMVIQ
|
October 7, 2021 Immunotherapeutic Benefits of the DPX Delivery Platform...
|
T.IVN
|
Oct 5 (Reuters) - Ivanhoe Mines Ltd: * IVANHOE MINES RESPONDS TO WESTERN...
|
IMVIQ
|
Potential Response Predictors to IMV’s Lead Compound in the DeCidE Clinical...
|
T.IVN
|
The low volumes are allowing day traders the opportunity to take advantage of...
|
IMVIQ
|
Over the past 10 days IMV has increased around 10% on no news. Not sure why...
|